DOAJ Open Access 2021

Underutilisation of breast cancer prevention medication in Australia

Courtney Macdonald James A. Chamberlain Danielle Mazza Roger L. Milne Kelly-Anne Phillips

Abstrak

Increased implementation of proven prevention strategies is required to combat rising breast cancer incidence. We assessed use of risk reducing medication (RRMed) by Australian women at elevated breast cancer risk. Only 2.4% had ever used RRMed. Higher breast cancer risk was statistically significantly associated with use of RRMed (OR 1.82, 95%CI: 1.08–3.07, p = 0.02 for ≥30% lifetime risk compared with 16%–29% lifetime risk), but parity, education level and family history of breast cancer were not. Breast cancer prevention medications are underutilised. Efforts are needed to incorporate breast cancer risk assessment and risk management discussions into routine health assessments for women.

Topik & Kata Kunci

Neoplasms. Tumors. Oncology. Including cancer and carcinogens

Penulis (5)

Courtney Macdonald

James A. Chamberlain

Danielle Mazza

Roger L. Milne

Kelly-Anne Phillips

Format Sitasi

APA MLA BibTeX

Macdonald, C., Chamberlain, J.A., Mazza, D., Milne, R.L., Phillips, K. (2021). Underutilisation of breast cancer prevention medication in Australia. https://doi.org/10.1016/j.breast.2021.08.013

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →

Lihat di Sumber doi.org/10.1016/j.breast.2021.08.013

Informasi Jurnal

Tahun Terbit: 2021
Sumber Database: DOAJ
DOI: 10.1016/j.breast.2021.08.013
Akses: Open Access ✓